Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A JAK2-V617F activating mutation in addition to KIT and FLT3 mutations is associated with clinical outcome in patients with t(8;21)(q22;q22) acute myeloid leukemia.

Haematologica - 1 Mar 2009

Iwanaga Eisaku, Nanri Tomoko, Matsuno Naofumi, Kawakita Toshiro, Mitsuya Hiroaki, Asou Norio

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Chromosomes, Human, Pair 21
Share to Chromosomes, Human, Pair 8

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to fms-Like Tyrosine Kinase 3

Share to Janus Kinase 2

Share to Leukemia, Myeloid

Share to Proto-Oncogene Proteins c-kit

Share to Translocation, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 19181784
DOI: 10.3324/haematol.13283
PMCID: PMC2649368

Genes

FLT3
JAK2
KIT

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A JAK2-V617F activating mutation in addition to KIT and FLT3 mutations is associated with clinical outcome in patients with t(8;21)(q22;q22) acute myeloid leukemia.PMID 19181784Read ↗

Acute myeloid leukemia harboring t(8;21)(q22;q22): a heterogeneous disease with poor outcome in a subset of patients unrelated to secondary cytogenetic aberrationsSemantic proximity Read ↗

Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group.Semantic proximity Read ↗

[Analysis of c-kit and JAK2 gene mutations in t(8;21) acute myeloid leukemia].Semantic proximity Read ↗

[Tyrosine kinase mutation and acute myeloid leukemia with T (8; 21)].Semantic proximity Read ↗

Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patientsSemantic proximity Read ↗

Cytogenetic analysis of acute myeloid leukemia with t(8;21) from a tertiary care center in India with correlation between clinicopathologic characteristics and molecular analysis.Semantic proximity Read ↗

A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemiaSemantic proximity Read ↗

A rare t(X;21)(p11;q22) in childhood acute myeloid leukemia: A case report and literature reviewSemantic proximity Read ↗

Prognostic Importance of C-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Systematic Review.Semantic proximity Read ↗

Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22).Semantic proximity Read ↗

Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications.Semantic proximity Read ↗

A novel t (5; 17) (q35; q21) associated with t (8; 21) (q22; q22) in a patient with acute myeloid leukemia: Case report and review of literatureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.